July 24, 2026 · Form 4 insider transaction
FRENKEL JACOB A bought 100,000 shares of Brainstorm Cell Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date.